Base Editing Now Able to Convert Adenine-Thymine to Guanine-Cytosine
Catherine Offord | Oct 25, 2017
With the arrival of a new class of single-nucleotide editors, researchers can target the most common type of pathogenic SNP in humans.
New Gene Therapy Shrinks Aggressive Tumors in Mice
Aggie Mika | May 1, 2017
Scientists shut down cancer-causing fusion genes with CRISPR.